Bruce L A Carter

Bruce L A Carter has an estimated net worth of $11.7 Million. This is based on reported shares across multiple companies, which include ENANTA PHARMACEUTICALS INC, ZYMOGENETICS INC, RENOVIS INC, Mirati Therapeutics, Inc., Xencor Inc, QLT INC/BC, ALSP Orchid Acquisition Corp I, and Regulus Therapeutics Inc..

2019 was Bruce L A Carter's most active year for acquiring shares with 9 total transactions. Bruce L A Carter's most active month to acquire stocks was the month of December. 2019 was Bruce L A Carter's most active year for disposing of shares, totalling 16 transactions. Bruce L A Carter's most active month to dispose stocks was the month of July. 2010 saw Bruce L A Carter paying a total of $1,183,300.20 for 457,500 shares, this is the most they've acquired in one year. In 2010 Bruce L A Carter cashed out on 894,750 shares for a total of $4,570,312.50, their largest year based on trade value.